Larimar Therapeutics (LRMR) Revenue: 2012-2019
Historic Revenue for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2019 value amounting to -$1.8 million.
- Larimar Therapeutics' Revenue rose 39.80% to -$301,000 in Q1 2020 from the same period last year, while for Mar 2020 it was -$1.6 million, marking a year-over-year increase of 19.23%. This contributed to the annual value of -$1.8 million for FY2019, which is 6.95% up from last year.
- According to the latest figures from FY2019, Larimar Therapeutics' Revenue is -$1.8 million, which was up 6.95% from -$1.9 million recorded in FY2018.
- In the past 5 years, Larimar Therapeutics' Revenue registered a high of -$165,000 during FY2017, and its lowest value of -$1.9 million during FY2018.
- Its 3-year average for Revenue is -$1.3 million, with a median of -$1.8 million in 2019.
- As far as peak fluctuations go, Larimar Therapeutics' Revenue surged by 68.81% in 2017, and later tumbled by 1,050.30% in 2018.
- Larimar Therapeutics' Revenue (Yearly) stood at -$806,000 in 2015, then spiked by 34.37% to -$529,000 in 2016, then spiked by 68.81% to -$165,000 in 2017, then slumped by 1,050.30% to -$1.9 million in 2018, then rose by 6.95% to -$1.8 million in 2019.